Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study

Jianqiu Wu, Jifeng Feng, Liping Su et al.|BMC Cancer|2016

Cited by 32